Open access · OA
via OpenAlex
Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease
Naomi P. Visanji, Connie Marras, Drew S. Kern, Amaal AlDakheel, Andrew F. Gao, Louis W. C. Liu, Anthony Edward Lang, Lili‐Naz Hazrati
Neurology · 2015 · ▲ 142 citations
Abstract
OBJECTIVE: To determine the utility of detecting a-synuclein (aSyn) in colonic mucosal biopsy tissue as a potential diagnostic biomarker for Parkinson disease (PD). METHODS: We used the paraffin-embedded tissue (PET) blot, which degrades physiologic nonaggregated aSyn using proteinase K and enhances antigen retrieval allowing sensitive and selective detection of remaining protein aggregates, to detect aSyn in colonic mucosal biopsies from 15 patients with early PD (,3 years), 7 patients with later PD (.5 years), and 11 individuals without PD. aSyn and serine 129–phosphorylated aSyn (Ser129p-aSyn) were assessed by PET blot and conventional immunohistochemistry. RESULTS: PET blot–resistant aggregated aSyn and Ser129p-aSyn was present in 12 of 15 individuals with early PD, 7 of 7 individuals with later PD, and 11 of 11 control subjects. The number of biopsies positive by PET blot relative to conventional immunohistochemistry was significantly lower in both PD groups compared with the control group for both aSyn and Ser129p-aSyn,whereas routine immunohistochemistry was positive more often in PD, but was positive in as many as 9 of 11 control individuals. CONCLUSION: Strong evidence of the presence of aggregated hyperphosphorylated aSyn in individuals with and without PD, using such a sensitive and specific method as the PET blot, suggests that colonic deposition of aSyn is not a useful diagnostic test for PD. The utility of detecting aSynin the colon as a biomarker in combination with other assessments remains to be determined.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1212/wnl.0000000000001240
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Visanji, N.P., Marras, C., Kern, D.S., AlDakheel, A., Gao, A.F., Liu, L.W.C., Lang, A.E., & Hazrati, L. (2015). Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease. <em>Neurology</em>. https://doi.org/10.1212/wnl.0000000000001240
Vancouver
Visanji NP, Marras C, Kern DS, AlDakheel A, Gao AF, Liu LWC, et al. Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease. Neurology. 2015. doi:10.1212/wnl.0000000000001240.
BibTeX
@article{naomi2015Coloni,
title = {Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease},
author = {Naomi P. Visanji and Connie Marras and Drew S. Kern and Amaal AlDakheel and Andrew F. Gao and Louis W. C. Liu and Anthony Edward Lang and Lili‐Naz Hazrati},
journal = {Neurology},
year = {2015},
doi = {10.1212/wnl.0000000000001240},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neuropathology and Applied Neurobiology 2018
Open access · CC-BY
Detection of alpha‐synuclein conformational variants from gastro‐intestinal biopsy tissue as a potential biomarker for Parkinson's disease
Movement Disorders 2011
Citation only
Alpha‐synuclein in colonic submucosa in early untreated Parkinson's disease
Neurology Research International 2025
Open access · CC-BY
Nuclear Alpha‐Synuclein in Parkinson’s Disease and the Malignant Transformation in Melanoma
Purdue e-Pubs (Purdue University System) 2010
Preprint
Role of alpha-synuclein primary structure and oxidative stress in Parkinson's disease pathology
npj Parkinson s Disease 2022
Open access · CC-BY
Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies
Parkinsonism & Related Disorders 2018
Citation only